Dalfampridine
Overview
Dalfampridine (4-amino pyridine) is used to improve walking in patients with multiple sclerosis. It acts by blocking potassium channels due to which conduction in focally demyelinated axons is increased because of which it enhances muscle contraction and thereby improves walking in patients
Categories
No Categories Defined
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Dalfampridine's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 10 to 10 mg | 10 (10) | 12 hourly | oral | Do not take more than two tablets in a 24 hr period.Take tablets whole .Do not crush , chew or dissolve tablets. The drug can be taken with or wothout food. Do not take the drug with other aminopyridine medications |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Dalfampridine is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Dalfampridine is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Dalfampridine
Back to top
Previous Drug Generic - Next Drug Generic